整体上看，遵医嘱进行术后辅助治疗预后良好，可有效提高患者生存期，降低各类复发风险，稳定获益。
参考文献：
[1] Silverstein M J, Epstein M S, Chen P, et al. Recurrence and survival rates for 1400 early breast tumors treated with intraoperative radiation therapy (IORT)[J]. Annals of Surgical Oncology, 2022: 1-11.
[2] Collin Lindsay J,Cronin-Fenton Deirdre P,Ahern Thomas P et al. Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women.[J] .Clin Cancer Res, 2021, 27: 1421-1428.
[3] Early Amy P,Moon Wong,Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction.[J] .Clin Breast Cancer, 2021, 21: e96-e101.
[4] Brackstone Muriel,Baldassarre Fulvia G,Perera Francisco E et al. Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.[J] .J Clin Oncol, 2021, 39: 3056-3082.
[5] Burstein H J,Curigliano G,Thürlimann B et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.[J] .Ann Oncol, 2021, 32: 1216-1235.
[6] Bredin Philip,Walshe Janice M,Denduluri Neelima,Systemic therapy for metastatic HER2-positive breast cancer.[J] .Semin Oncol, 2020, 47: 259-269.
[7] Park YH, Senkus-Konefka E, Im SA, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS [published online ahead of print, 2020 Jan 16]. Ann Oncol. 2020;S0923-7534(20)35929-9. doi:10.1016/j.annonc.2020.01.008.
[8] Heil J,Kuerer H M,Pfob A et al. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.[J] .Ann Oncol, 2020, 31: 61-71.
